(APVO) |
| 0 (0%) 10-12 13:48 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.99 |
| Resistance 1: | 1.88 |
| Pivot price: | 1.83 |
| Support 1: | 1.71 |
| Support 2: | 1.42 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 66.590 |
| Book Value | 4.260 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -111.5 |
| Return on Equity (ttm) | -420.3 |
Company news
Fri, 09 Oct 2026
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Treasure Coast News
Mon, 05 Oct 2026
Aptevo Therapeutics (APVO) Ticks Higher: Shares Gain 1.41% to $1.80 as Range Persists - Outside Reversal - https://www.siam.in/
Thu, 24 Sep 2026
Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development - Stock Titan
Mon, 21 Sep 2026
Aptevo Therapeutics (APVO) Edges Lower to $1.82 as Shares Hold Above $1.73 Support - Factor Timing - https://www.dars.gov.et/
Mon, 31 Aug 2026
Aptevo Therapeutics Inc. (APVO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Mon, 24 Aug 2026
APVO: Focusing on Three Key Areas of Development - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
